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TORC1 regulates growth and metabolism, in part,
by influencing transcriptional programs. Here, we
identify REPTOR and REPTOR-BP as transcription
factors downstream of TORC1 that are required for
90% of the transcriptional induction that occurs
upon TORC1 inhibition in Drosophila. Thus, REPTOR
and REPTOR-BP aremajor effectors of the transcrip-
tional stress response induced upon TORC1 inhibi-
tion, analogous to the role of FOXO downstream of
Akt. We find that, when TORC1 is active, it phos-
phorylates REPTOR on Ser527 and Ser530, leading
to REPTOR cytoplasmic retention. Upon TORC1 inhi-
bition, REPTOR becomes dephosphorylated in a
PP2A-dependent manner, shuttles into the nucleus,
joins its partner REPTOR-BP to bind target genes,
and activates their transcription. In vivo functional
analysis using knockout flies reveals that REPTOR
and REPTOR-BP play critical roles in maintaining
energy homeostasis and promoting animal survival
upon nutrient restriction.
INTRODUCTION
Target of rapamycin complex 1 (TORC1) integrates information
on energy and nutrient status in eukaryotic cells. Under high-
nutrient and -energy conditions, TORC1 drives translation, ribo-
some biogenesis, mitochondrial activity, lipid synthesis, nucleo-
tide synthesis, and glycolysis (Dibble and Manning, 2013).
TORC1, thereby, couples activity of cellular anabolic and cata-
bolic pathways to nutrient and energy supply (Sengupta et al.,
2010b). TORC1 is frequently mis-regulated in diseases such as
cancer, diabetes, obesity, and neurodegeneration (Cornu et al.,
2013; Menon and Manning, 2008; Zoncu et al., 2011).
TORC1 regulates growth and metabolism by phosphorylating
target proteins, such as S6K and 4E-BP, involved in translational
regulation (Hay and Sonenberg, 2004;Ma andBlenis, 2009;Mor-
ita et al., 2013; Thoreen et al., 2012). Phosphorylation of targets
changes very rapidly upon altered TORC1 activity (Kang et al.,272 Developmental Cell 33, 272–284, May 4, 2015 ª2015 Elsevier Inc2013), allowing cells to adapt quickly to changing environmental
conditions. In addition, TORC1 also has long-lasting impact on
cellular behavior through the control of transcriptional programs
(Du¨vel et al., 2010; Guertin et al., 2006). This occurs by directly or
indirectly modulating the activity of transcription factors such as
SREBP, HIF1a, PGC-1a, TIF1a, PPARa, Atf4 (CREB2), TFEB,
and TFE3 (Csibi et al., 2013; Cunningham et al., 2007; Du¨vel
et al., 2010; Horton et al., 2002; Hudson et al., 2002; Kim et al.,
2012; Martina et al., 2014; Mayer et al., 2004; Peterson et al.,
2011; Roczniak-Ferguson et al., 2012; Sengupta et al., 2010a).
The TORC1 signaling pathway is highly conserved through
evolution (Kapahi et al., 2010), thereby enabling the use of model
organisms such as Drosophila for discovery of novel pathway
components (Saucedo et al., 2003; Stocker et al., 2003). Recent
studies inDrosophila analyzed the impact of TORC1 signaling on
cellular transcription (Guertin et al., 2006; Zinke et al., 2002). In
Drosophila S2 cells, inhibition of TORC1 with rapamycin leads
to numerous transcriptional changes (Guertin et al., 2006).
Genes involved in anabolic processes such as ribosome biogen-
esis are strongly repressed upon TORC1 inhibition. We previ-
ously showed that this occurs via downregulation of myc activity
(Teleman et al., 2008). A second class of genes is activated upon
TORC1 inhibition. Although the function of these genes is less
understood, they probably represent the genes needed for cells
to adapt to conditions yielding reduced TORC1 activity, such as
low nutrient availability. We aimed to find the transcription factor
responsible for mediating this upregulation upon TORC1 inhibi-
tion. Here, we report the discovery of these factors, which, sur-
prisingly, are required for mediating most of the transcriptional
induction that takes place upon TORC1 inhibition and play
important roles in maintaining energy homeostasis in vivo.
RESULTS
REPTOR and REPTOR-BP Are Required for Activation of
a Rapamycin-Inducible Transcriptional Reporter in S2
Cells
To identify the transcription factors responsible for upregulating
target genes uponTORC1 inhibition,wegenerated a luciferase re-
porter that recapitulates this regulation. We cloned promoter and/
or intronic sequences from early-induced target genes (Guertin
et al., 2006) into a luciferase reporter and found a 1.4-kb genomic
fragment from the unkgene thatwas 2-fold inducedwhenS2 cells.
Figure 1. REPTOR and REPTOR-BP Are
Required for Induction of unk Expression
in Response to TOR Inhibition
(A) Schematic representation of the unk gene lo-
cus and unk luciferase reporter. TSS, transcrip-
tional start site.
(A’) Rapamycin (Rapa) (7.5 nM, 6 hr) induces
expression of the unk reporter in S2 cells. Ctrl,
control.
(B) Outline of RNAi screen to identify transcription
factors required for rapamycin-mediated induc-
tion of the unk reporter. d, days.
(B’) CG18619 or CG13624 knockdown blunts in-
duction of the unk reporter in response to rapa-
mycin (20 nM, 6 hr).
(C) CG13624 and CG18619 are required for ra-
pamycin (20 nM, 2 hr) to induce transcription of
endogenous unk. mRNA levels measured by qRT-
PCR, normalized to rp49.
(D) Overexpression of CG13624 or CG18619 in-
duces the unk reporter in S2 cells.
(E) CG13624 and CG18619 bind each other. coIP
of CG13624-HA with myc-CG18619 in S2 cells.
ins, insulin; tub, tubulin.
Error bars indicate SD. **p < 0.01, Student’s t test;
***p < 0.001, Student’s t test; n.s., not significant.are treatedwith rapamycin for 6 hr (FigureS1A). Truncationsof this
fragment identified a minimal 332-bp region from unk intron 2,
capable of inducing luciferase transcription 2.8-fold (Figure S1A).
Further truncation of this fragment caused the rapamycin res-
ponse to be progressively lost (Figure S1A). Tomake this reporter
suitable for screening, we dimerized the enhancer (Figure 1A),
yielding a reporter that is activated 10-fold after 6 hr rapamycin
treatment (Figure 1A’). This reporter is induced in a dose-depen-
dent manner by TORC1 inhibition with rapamycin or Torin1 (Fig-
ure S1B) (Liu et al., 2010; Thoreen et al., 2009) and is repressed
by TORC1 hyperactivation (Figure S1C). Previous reports found
that fork head (fkh) and Lipin (Lpin) mediate part of the transcrip-
tional output of TORC1 (Bu¨low et al., 2010; Peterson et al.,
2011).Neither fkhnor Lpin knockdownsignificantly blunted induc-
tionof theunk reporter (FiguresS1EandS1E’) or of apanel of other
genes upon rapamycin treatment (Figure S1D, with the exception
of ash2 and 4EBP), suggesting that additional transcriptional me-
diators remain to be discovered.Developmental Cell 33, 272To find transcription factors that upre-
gulate the unk reporter upon TORC1 inhi-
bition, we performed anRNAi screen in S2
cells. We depleted cells of all 1,002 genes
with predicted DN-binding activity indi-
vidually (Table S1) and tested for unk
reporter induction upon rapamycin treat-
ment (Figure 1B). Thereby, we identified
two uncharacterized genes, CG13624
and CG18619, to be required for rapamy-
cin-mediated unk reporter activation (Fig-
ure 1B’). Knockdown of CG13624 or
CG18619 also blunted induction of the
endogenous unk gene (Figure 1C), without
obvious effects on cell size or viability(data not shown). Conversely, when overexpressed, CG13624
and CG18619 could activate the unk reporter (Figure 1D). Since
proteome-wide protein-protein interaction screens suggested
that CG13624 and CG18619 can bind each other (Guruharsha
et al., 2011), we tested if they interact by co-immunoprecipitation
(coIP). Indeed, myc-CG18619 co-immunoprecipitatedCG13624-
HA (Figure 1E) and the other way around (Figures S1F and S1F’).
Furthermore, CG18619 was also able to homodimerize (Fig-
ure S1H). Based on these data, we hypothesized that CG13624
and CG18619 act as a transcriptional activator complex that is
repressed by TORC1 and calledCG13624 ‘‘REPTOR’’ (repressed
by TOR) andCG18619 ‘‘REPTOR-BP’’ (REPTOR-binding partner)
(Figure S1I).
Using SMART (the Simple Modular Architecture Research
Tool) (Letunic et al., 2012), we found that REPTOR and
REPTOR-BP contain basic region leucine zippers (BRLZs; Fig-
ure S1I). This domain mediates both homo/hetero-dimerization
and DNA binding through an adjacent basic region (Vinson–284, May 4, 2015 ª2015 Elsevier Inc. 273
Figure 2. REPTOR and REPTOR-BP Are
Required for Activation of Almost All Rapa-
mycin-Induced Genes in S2 Cells
(A) REPTOR and REPTOR-BP are required for
transcriptional activation of ash2 and stai after
rapamycin (Rapa) treatment (20 nM, 2 hr). mRNA
levels were measured by qRT-PCR and normal-
ized to rp49. Error bars indicate SD. Ctrl, control.
(B) Knockdown of REPTOR or REPTOR-BP pre-
vents induction of almost all rapamycin-induced
genes in S2 cells. Table shows all genes that
are induced or repressed at least 1.5-fold (with
p < 0.05) after rapamycin treatment (20 nM, 2 hr)
in each knockdown condition (from microarray
analysis).
(C and D) REPTOR or REPTOR-BP knockdown
(kd) affects genes whose expression is induced by
rapamycin (C) but not genes whose expression is
repressed by rapamycin (20 mM, 2 hr) (D). All
genes whose expression changes upon rapamy-
cin treatment in control S2 cells with p < 0.05 are
shown (x axis). The y axis indicates corresponding
fold change in the REPTOR or REPTOR-BP
knockdown cells.et al., 1989). DNA-binding specificity is determined by the
homo- or heterodimer that is formed. To test whether REPTOR
and REPTOR-BP interact via their BRLZ domains, we per-
formed serial N-terminal truncations of REPTOR, leaving the
BRLZ domain intact, and tested whether these fragments
interact with REPTOR-BP. Indeed, all fragments of REPTOR,
including a short one that consists of only the BRLZ domain
(DN3), co-immunoprecipitated with REPTOR-BP (Figure S1G).
In sum, REPTOR and REPTOR-BP form a complex required
for the upregulation of unk and the unk reporter upon TORC1
inhibition.
Almost All Genes that Are Transcriptionally Induced by
Rapamycin Are REPTOR and REPTOR-BP Dependent
In addition to unk, other genes, such as ash2 and stai, are
induced by rapamycin in S2 cells (Guertin et al., 2006). Upregu-
lation of ash2 and stai was also REPTOR and REPTOR-BP
dependent (Figure 2A), suggesting a more general role for
REPTOR and REPTOR-BP in regulating transcription down-
stream of TORC1. To test this, we performed genome-wide
expression analysis on cells treated with double-stranded RNA
(dsRNA) against REPTOR, REPTOR-BP, or GFP (as a control)
and subsequently treated for 2 hr ± rapamycin. In control knock-
down cells, 202 genes were induced, and 231 genes were down-
regulated by rapamycin (Figure 2B, GFP). Strikingly, in cells
depleted of REPTOR or REPTOR-BP, only 30 and 8 genes274 Developmental Cell 33, 272–284, May 4, 2015 ª2015 Elsevier Inc.were induced, respectively (Figure 2B).
Hence, 90% of all genes repressed by
TORC1 in S2 cells are downstream of
REPTOR and REPTOR-BP. This can be
visualized by plotting fold change upon
rapamycin treatment for all genes that
are significantly (p < 0.05) induced in
control cells (Figure 2C, x axes) versus
knockdown cells (Figure 2C, y axes),with equal induction in both conditions on the diagonal. Almost
all genes lie off the diagonal, indicating that they are induced
in control S2 cells but not in REPTOR knockdown cells. In
contrast, genes repressed by rapamycin treatment are equally
well repressed in the presence or absence of REPTOR and
REPTOR-BP (Figure 2D). Hence, REPTOR and REPTOR-BP
are specifically required for the class of genes induced upon
TORC1 inhibition. These microarray data were confirmed by
randomly picking strongly and weakly induced genes and
measuring their mRNA levels by qRT-PCR (Figure S2A).
189 genes require both REPTOR and REPTOR-BP for their in-
duction in response to TORC1 inhibition, whichwe define here as
‘‘REPTOR target genes’’ (Figure S2B; Table S2). When subjected
to gene ontology (GO) term enrichment analysis, REPTOR target
genes were not strongly enriched for a specific biological pro-
cess, based on current GO term annotations, but were generally
involved in ‘‘metamorphosis’’ and ‘‘development’’ (p < 0.002;
Figure S2C). REPTOR target genes include genes from the insu-
lin/insulin growth factor (IGF) and the target of rapamycin (TOR)
signaling pathway itself (4E-BP, chico, Rheb), genes involved in
autophagy (Atg8a, Atg9, Atg2), metabolic enzymes (alpha-Est3,
Glycogenin), and mitochondrial regulators (Pink1, Marf) (Fig-
ure S2D), processes linked to TORC1 signaling in previous
studies (Cunningham et al., 2007; Kim et al., 2011; Morita
et al., 2013; Scott et al., 2004). In sum, REPTOR and REPTOR-
BP appear to be the main transcription factors responsible for
mediating 90% of the transcriptional repression downstream
of TORC1 in S2 cells.
TORC1Controls the Subcellular Localization of REPTOR
to Control Target Gene Expression in S2 Cells
The data in Figure 1 suggest that REPTOR and REPTOR-BP are
repressed under normal culture conditions and become active
when TORC1 is inhibited. To study the underlying mechanism,
we tested whether TORC1 activity abrogates binding between
REPTOR and REPTOR-BP. However, REPTOR-HA binds myc-
REPTOR-BP under both high- and low-TORC1 conditions (Fig-
ures 1E and S1F), ruling out this hypothesis. Of note, the condi-
tions used for this coIP experiment completely rupture the cells,
allowing cytoplasmic and nuclear proteins to mix in the lysate.
Therefore, it only assays the binding affinity between REPTOR
and REPTOR-BP but does not take into account the subcellular
partitioning of REPTOR and REPTOR-BP in intact cells. To
address this, we studied the subcellular localization of REPTOR
and REPTOR-BP. REPTOR-BP is constitutively nuclear, regard-
less of TORC1 activity (Figure 3A, in red). In contrast, REPTOR
was enriched in the cytoplasm under normal culture conditions
(data not shown) or in the presence of insulin (Figure 3A, top
panels; Figure S3A), and it translocated into the nucleus upon
TORC1 inhibition with rapamycin or Torin1 for 30 min (Figure 3A,
lower panels; Figures S3A, S3C, and S3C’). To confirm these
findings with endogenous REPTOR, we fractionated S2 cells
into nuclear and cytoplasmic fractions and found that endoge-
nous REPTOR (Figure S3B) also accumulated in the nuclear frac-
tion upon rapamycin treatment (Figure 3B, lanes 1–4). These data
suggest that TORC1 represses REPTOR by inhibiting its nuclear
accumulation, in a manner analogous to that of Akt and FOXO.
S6Kmediates a large number of outputs of TORC1 (Ben-Sahra
et al., 2013; Wang et al., 2001; Zoncu et al., 2011). To test
whether TORC1 is acting on REPTOR directly or indirectly via
S6K, we first asked if REPTOR binds directly to TORC1. Indeed,
REPTOR can co-immunoprecipitate raptor, a component of
TORC1 (Figures 3C and 3C’) (Hara et al., 2002), suggesting
that the regulation might be direct. Then, we asked if TORC1
keeps REPTOR inactive via S6K, but this was not the case;
S6K knockdown did not induce the unk reporter in the absence
of rapamycin, even when S6K protein amounts were knocked
down to undetectable levels (Figures 3D and D’). Thus, TORC1
appears to regulate REPTOR directly and independently of S6K.
Since TORC1 is a protein kinase, the most simple explanation
would be that it phosphorylates REPTOR, thereby causing its
cytoplasmic retention. To identify possible phosphorylation
sites, we delineated the region of REPTOR protein required to
regulate its subcellular localization. Successive N-terminal trun-
cations of REPTOR showed that the first 500 amino acids are
dispensable for regulating its subcellular localization, whereas
further truncations led to a protein that was constitutively nuclear
(Figure S3D), suggesting that the region around amino acid 520
contains regulatory information. To pinpoint the phosphorylated
residues in REPTOR, we mutated 24 serines and threonines to
alanine to mimic dephosphorylation and searched for mutations
rendering REPTOR constitutively nuclear. For instance, a mutant
form of REPTOR simultaneously containing 16 alaninemutations
(T116A/S457A/S487A/S504A/S505A/T508A/T528A/T542A/S587A/
S595A/ S596A/S639A/T665A/T689A/S762A/S763A) still shut-Devtled correctly in response to rapamycin treatment (data not
shown). In contrast, the combined mutation of two serines
(S527A and S530A) in the regulatory region identified by the
truncation analysis (Figure S3D) rendered REPTOR constitutively
nuclear, even in the presence of TORC1 activity (Figures 3E and
3E’). Targeted mass spectrometry analysis of REPTOR-HA
immunoprecipitated from S2 cells confirmed that these two
serines are phosphorylated when TORC1 is active (Figure 3F,
‘‘Ins’’) and de-phosphorylated when TORC1 is inhibited with
rapamycin for 30 min (Figure 3F, ‘‘Ins + Rapa’’). By probing
immunoprecipitated REPTOR with a phospho-specific antibody
recognizing REPTOR doubly phosphorylated on S527 and
S530, we confirmed that these sites are phosphorylated only
when TORC1 is active (Figure 3G).
Cytoplasmic retention of phospho-proteins can be mediated,
in part, by binding to 14-3-3 proteins. An unbiased screen for
REPTOR-binding partners, whereby REPTOR co-immunopreci-
pitating proteins were analyzed by mass spectrometry, identi-
fied 14-3-3 proteins as one of the strongest interacting partners
(Figure S3E; Table S3). Interestingly, this interaction was
drastically reduced in rapamycin-treated cells (Figure S3E). In
agreement with the data presented earlier, we also detected
strong interactions with endogenous REPTOR-BP and TOR ki-
nase in this analysis (Figure S3E). To validate the 14-3-3 results,
we raised antibodies against Drosophila 14-3-3 proteins (Fig-
ure S3F) and found that endogenous 14-3-3ε and 14-3-3z
bind REPTOR-HA in a TORC1-dependent manner (Figures 3H
and S3G).
Upon rapamycin treatment, REPTOR becomes quickly de-
phosphorylated (Figure 3G), indicating active dephosphorylation
by a phosphatase. Among the REPTOR-interacting proteins
identified by mass spectrometry were subunits of protein phos-
phatase 1 (PP1) and 2A (PP2A) (Figure S3H). PP2A caught our
attention, since PP2A dephosphorylates components of the in-
sulin/IGF-TOR pathway (Hahn et al., 2010). To test the require-
ment of PP2A for REPTOR de-phosphorylation, we inhibited
PP2A with okadaic acid (OA) and found that this completely
abrogated nuclear accumulation of REPTOR (Figure 3B, lanes
5–8; Figure 3I). OA also causes an upshift of REPTOR protein
(Figure 3B) in agreement with REPTOR being phosphorylated
on many additional sites that are not insulin or rapamycin
responsive (Figure S1I). To ensure specificity, OA was used at
a concentration of 50 nM, the minimum required to block de-
phosphorylation of S6K on T398 upon TORC1 inhibition (Fig-
ure S3I) (Hahn et al., 2010).
In sum, these data suggest that, when TORC1 is active,
REPTOR is phosphorylated and kept in the cytoplasm, in part,
by interaction with 14-3-3 proteins. Upon TORC1 inhibition,
REPTOR becomes dephosphorylated, in part via PP2A, and
shuttles into the nucleus.
REPTOR Has Transactivation Activity and Binds Target
Genes Together with REPTOR-BP
To understand how REPTOR and REPTOR-BP activate tran-
scription, we fused REPTOR or REPTOR-BP to the DNA-binding
domain (DBD) of GAL4 and assayed their ability to activate tran-
scription of a luciferase reporter bearing GAL4-binding sites
(UAS) (Figure 4A). This assay revealed that REPTOR has
strong transactivation activity, whereas REPTOR-BP does notelopmental Cell 33, 272–284, May 4, 2015 ª2015 Elsevier Inc. 275
Figure 3. REPTOR Is Sequestered in the Cytoplasm by TORC1-Mediated Phosphorylation
(A) REPTOR shuttles into the nucleus upon rapamycin (Rapa) treatment (20 nM, 30 min). REPTOR-HA and myc-REPTOR-BP co-transfected in S2 cells and were
analyzed by immunostaining. Scale bar, 10 mm.
(B) Endogenous REPTOR accumulates in the nucleus upon rapamycin treatment (20 nM, 30 min). S2 cells were fractionated into cytoplasmic (Cyt) and nuclear
fractions (Nuc) prior to immunoblotting. +OA: 50 nM OA added 15 min prior to rapamycin addition (lanes 5–8). LE, long exposure; SE, short exposure. ns,
nonspecific.
(C and C’) REPTOR interacts with TORC1. HA-raptor co-immunoprecipitates with REPTOR-myc in S2 cells.
(D andD’) unk reporter activation is independent of S6K. S2 cells efficiently depleted of S6K (D’), transfectedwith unk reporter and treatedwith rapamycin (7.5 nM,
6 hr) (D). Error bars indicate SD. Ctrl, control; LE, long exposure; SE, short exposure.
(E and E’) Ser527 and Ser530 are required for cytoplasmic retention of REPTOR. Mutation of Ser527 and Ser530 to alanine (REPTOR[AA]-HA) results in
constitutive nuclear localization (S2 cells, rapamycin, 20 nM for 30 min). Scale bars, 10 mm.
(F and G) S527 and S530 are both phosphorylated (Phos) and become dephosphorylated upon rapamycin treatment (20 nM, 30 min). In (F), relative levels of
doubly phosphorylated pS527/pS530 were detected by mass spectrometry on immunoprecipitated REPTOR-HA. Each treatment condition was normalized
separately. Error bars indicate SD. In (G), double phosphorylation on S527/S530, detected using a phospho-specific antibody (pREPTOR) on immunoprecipitated
REPTOR-HA, is abolished upon rapamycin treatment. Ins, insulin.
(legend continued on next page)
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(Figure 4A’). The transactivation activity of REPTOR did not
require REPTOR-BP (Figure 4A’’).
Our data indicate that, of the two proteins in the REPTOR/
REPTOR-BP complex, REPTOR is the protein regulated by
TORC1 phosphorylation, that shuttles in and out of the nucleus,
and that has transactivation capacity. This left us with no clear
function for its binding partner REPTOR-BP, despite REPTOR-
BP being required for activation of target genes (Figures 1B’
and 2). We suspected that REPTOR-BP might help accumulate
REPTOR in the nucleus upon TORC1 inhibition, but this was
not the case (Figures S4B and S4B’). Alternatively, REPTOR-
BP could help recruit REPTOR to target genomic DNA—a
function performed artificially by the GAL4 DBD in the tran-
sactivation assay (Figures 4A and 4A’’). To test this, we per-
formed chromatin immunoprecipitation (ChIP) experiments
on REPTOR-myc from S2 cells. Upon rapamycin treatment,
REPTOR binds strongly to DNA within the second intron of
unk, the region from which the unk reporter is derived (Figures
4B and 4B’)—confirming that unk is a direct transcriptional
target of REPTOR—as well as to the promoter regions of
all target genes that we tested, such as 4E-BP, CG16721,
REPTOR-BP, CG6770, and CG11658 (Figures 4B’’ and S4A).
In contrast, REPTOR did not bind a control intergenic region
downstream of unk (Figures 4B and 4B’, ‘‘unk IGS’’). ChIP of
the binding partner REPTOR-BP revealed that it binds unk
intron 2 as well as the intergenic region downstream of unk
(Figure 4C). Although binding of REPTOR-BP increases upon
rapamycin treatment, it also binds chromatin in the absence
of rapamycin (Figure 4C). To test whether REPTOR-BP helps
REPTOR bind target genes, we performed a REPTOR ChIP
from cells treated with REPTOR-BP dsRNA. When REPTOR-
BP is depleted, REPTOR is unable to bind target genes effi-
ciently upon rapamycin treatment (Figure 4D), despite its
entering the nucleus (Figure S4B). Thus, REPTOR-BP resides
constitutively in the nucleus and helps REPTOR bind target
DNA.
To study REPTOR-BP binding genome-wide, we performed a
REPTOR-BP ChIP and sequenced the bound DNA. This re-
vealed that REPTOR-BP binds 2,300 regions genome-wide in
the presence of rapamycin (Figure S4D; Table S5), including
the promoter regions of target genes such as CG6770 and
PEPCK (Figures S4E and S4E’). Almost all of these regions are
also bound by REPTOR-BP in the absence of rapamycin (Figures
S4D–S4E’; Table S5), suggesting that REPTOR-BP is always
present at these locations.
To identify a possible binding motif for REPTOR-BP or the
REPTOR/REPTOR-BP dimer, we performed a motif search on
the REPTOR-BP-bound regions usingMEME-ChIP software (Ma-
chanick and Bailey, 2011). Interestingly, this identified the FOXO-
binding motif GTAAACAA (Teleman et al., 2008) as the most en-
riched motif (Figure S4F), suggesting that REPTOR/REPTOR-BP
and FOXObind the same enhancer regions. In addition, othermo-
tifswere significantly enriched (Figure S4F). Then, we scanned the
332-nt unk reporter region and found 8 nt at the 30 end of the re-(H) REPTOR interacts with 14-3-3 proteins only when TORC1 is active. REPTOR
(eps) and zeta.
(I) Dephosphorylation of REPTOR-HA by PP2A is required for nuclear accumulat
REPTOR-HA, treated with 50 nM OA 15 min prior to rapamycin treatment. Scale
Devporter required for rapamycin responsiveness (Figure S4G). We
mutated each of these 8 nt to all other possible nucleotides,
thereby obtaining a matrix of possible sequences that support ra-
pamycin induction (Figure S4G). Interestingly, this sequence has
similarities to the motifs identified in the REPTOR-BP ChIP (Fig-
ure S4F). Unfortunately, we were not able to test whether these
are REPTOR- or REPTOR-BP-binding sequences, as we were
not able to obtain soluble recombinant proteins for gel-shift
assays.
Since progressive truncation of the 332-nt unk reporter from
the 50 end leads to progressive loss in enhancer activity (Fig-
ure S1A), we wondered whether epigenetic mechanisms might
be at play that spread over the chromatin. Indeed, ChIP analysis
revealed that histone 3 lysine 9 acetylation (H3K9ac), a mark
associated with promoter and enhancer activation (Ernst et al.,
2011), increases specifically in the unk reporter region after rapa-
mycin treatment (Figures 4E and 4E’). This increase is not due to
an overall increase in transcription of the area, as a slightly more
upstream region (unk exon 2) did not show such an increase (Fig-
ure 4E’). As a control, H3K4me3, also associated with promoter
and enhancer activation (Ernst et al., 2011), did not increase (Fig-
ure S4C). Hence, REPTOR might be inducing transcription, in
part, via recruitment of epigenetic factors, although further
work will be required to study this in detail.
REPTOR and REPTOR-BP Regulate Organismal
Metabolism
We asked whether REPTOR activity is also regulated by TORC1
in the animal. We generated transgenic flies carrying the unk
luciferase reporter (Figure 1A) and equivalent control flies car-
rying a reporter lacking the unk region. Both unk and control re-
porters were integrated into the fly genome at exactly the same
position by phiC31-mediated site-directed integration, yielding
two fly strains that are genetically identical except for the pres-
ence or absence of the 332-bp unk enhancer. This controls for
all transcriptional effects besides the 332-bp unk enhancer. As
in S2 cells, the unk reporter, but not the control reporter, is acti-
vated by feeding rapamycin to larvae or adults (Figure 5A; Fig-
ures S5A and S5B). To generate a tool for assaying inhibition
of TORC1 in vivo, we generated flies carrying a GFP/lacZ version
of the unk reporter. Inhibition of TORC1 in a stripe down the mid-
dle of the wing imaginal disc, by expressing PRAS40 (Pallares-
Cartes et al., 2012) with patched-GAL4, led to amarked increase
in reporter expression (Figure S5C), confirming that this reporter
can monitor TORC1 inhibition in vivo.
We generated knockout (KO) flies lacking all of the REPTOR
open reading frame (ORF) (Figure S5D) or most of the
REPTOR-BP ORF (Figure S5D’). In REPTOR KOs, induction of
the unk reporter was completely abolished (Figure 5A), indicating
that the unk reporter is a good readout for REPTOR activity, as
well as TORC1 activity, in vivo. Consistent with the activation be-
ing direct, we could detect robust induction of reporter expres-
sion at the mRNA level already 30 and 120 min after rapamycin
feeding (Figure S5A). REPTOR activity was also induced in larvae-HA immunoprecipitates immunoblotted to detect endogenous 14-3-3 epsilon
ion upon rapamycin treatment (20 nM, 30 min). S2 cells were transfected with
bar, 25 mm.
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Figure 4. REPTOR Directly Binds and Transactivates Target Genes
(A) Schematic of the transactivation assay used in (A’)–(A’’).
(A’) REPTOR, but not REPTOR-BP, shows transactivation activity when fused to the GAL4 DBD (insulin [Ins] 6 hr, 10 mg/ml; rapamycin [Rapa], 6 hr, 20 nM).
(A’’) REPTOR transactivation activity does not require REPTOR-BP. S2 cells were treated with dsRNA against GFP or REPTOR-BP 5 days before assay.
(B–B’’) Rapamycin treatment (20 nM, 30 min) strongly increases REPTOR binding to target genes. (B) Diagram of qPCR oligos used for ChIP analysis in (B’)–(D).
(B’ and B’’) REPTOR-myc ChIP, analyzed by qPCR. Ctrl IP, control IP; IGS, intergenic sequence.
(C) REPTOR-BP binds constitutively to DNA, also in the absence of rapamycin (20 nM, 30 min). ChIP using myc antibody from S2 cells stably transfected with
myc-REPTOR-BP. Ctrl, control.
(D) REPTOR-BP recruits REPTOR to target genes after rapamycin treatment (20 nM, 30min). ChIP against REPTOR-myc after 5-day knockdown of REPTOR-BP.
(E and E’) H3K9ac is specifically enriched in the unk reporter region after rapamycin treatment (20 nM, 30min) compared to control treatment (vehicle only, EtOH).
ChIP was conducted with H3 and H3K9ac antibodies from S2 cells. Control ChIP was conducted with beads with no primary antibody.
Error bars indicate SD. *p < 0.05, Student’s t test; **p < 0.01, Student’s t test; ***p < 0.001, Student’s t test; n.s., not significant.
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Figure 5. REPTOR and REPTOR-BP Are Required for Rapamycin-Induced Transcription In Vivo and Regulate Metabolism in Drosophila
(A and A’) Unk-reporter activity is induced in vivo upon nutrient withdrawal or TORC1 inhibition in a REPTOR-dependent fashion. Unk-reporter luciferase activity,
normalized to total protein, in 24-hr prewandering control (Ctrl) and REPTOR-KO larvae fed with rapamycin (Rapa) (200 mM, 5 hr) (A) or starved (Starv) (0.8%
agarose/PBS, 4 hr) (A’). WT, wild-type.
(B and B’) REPTOR (B) and REPTOR-BP (B’) are required in vivo in larvae for induction of genes in response to rapamycin. 24 hr prewandering control or KO larvae
fed with rapamycin (200 mM, 5 hr). mRNA levels were measured by qRT-PCR, normalized to rp49.
(C and C’) REPTOR (C) and REPTOR-BP (C’) KO flies have very low triglyceride stores (4-day-old adults, normalized to weight).
(D and D’) REPTOR (D) and REPTOR-BP (D’) KO flies have reduced glycogen stores. Glycogen levels of 2-day-old (D) and 6-day-old (D’) flies, normalized to
protein content.
(E and E’) REPTOR (E) and REPTOR-BP (E’) KO flies are extremely sensitive to starvation. Four-day-old male flies were starved on 0.8% agarose/PBS.
(F) REPTOR KO larvae are sensitive to nutrient stress. Larvae were grown on food diluted to 25% of the normal concentration in PBS/agarose or on food
containing only 10% protein of the standard food or food containing 0.01% H2O2.
(G) FOXO and REPTOR mutations are synthetic lethal. Number of live, homozygous first instar (L1) larvae compared to the number of expected homozygous
animals under growth-controlled conditions.
Error bars indicate SD. *p < 0.05, Student’s t test; **p < 0.01, Student’s t test; ***p < 0.001, Student’s t test; n.s., not significant.
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and adult flies upon nutrient withdrawal (Figures 5A’ and S5E),
indicating that REPTOR, via TORC1, is sensitive to physiological
perturbations in nutrient status. Mated females responded
strongly to 24-hr nutrient deprivation, whereas virgin females
did not, perhaps because of the increased metabolic demands
of egg laying in mated females (Figure S5E). Luciferase assays
on tissues isolated from fed or starved animals showed induction
of the unk reporter in all tissues (Figure S5F), in agreement with
REPTOR and REPTOR-BP being expressed ubiquitously in the
animal (Figures S5G and S5H). Overexpression of dominantly
active REPTOR (Figures 3E–3G, ‘‘REPTOR[AA],’’) induces target
gene expression in wing imaginal discs more strongly than wild-
type REPTOR (Figures S5I and S5I’), indicating that these two
sites regulate REPTOR activity also in vivo.
We asked whether REPTOR and REPTOR-BP mediate a large
fraction of the transcriptional response to TORC1 inhibition also
in flies. Microarray expression analysis revealed that 407 genes
are induced and 377 are repressed at least 2-fold (with p <
0.01) upon 6-hr rapamycin feeding of control larvae and that
90% of the induced (380) and 80% of the repressed genes
do so in a REPTOR-dependent manner (Figure S2E; Table S4).
The overlap of regulated genes in larvae versus S2 cells is not
100% (Figure S2F) likely, because larvae are a mixture of many
different tissue types. These results were confirmed by qRT-
PCR on a panel of genes from a separate biological replicate,
with rapamycin-mediated induction of these genes being com-
pletely dependent on REPTOR and REPTOR-BP in vivo (Figures
5B and 5B’). GO analysis on REPTOR target genes induced
by rapamycin in larvae revealed an enrichment for stress
response genes and genes involved in metabolic processes
(e.g., glutamine synthetase 1, glutamine synthetase 2, alpha/
beta hydrolase 2, alpha-Esterase-1, CG31683) (Figure S2G).
Repressed genes were enriched for protein transport and
folding, with 39% of them also involved in metabolic processes
(Figure S2G’).
Drosophila larvae eat continuously and grow very rapidly.
Once they reach the correct final size, they stop eating and pu-
pate to become adults. Several data indicate that REPTOR activ-
ity is low during the nutrient-rich, rapid-growth stages of larval
development, when TORC1 activity is high, and that REPTOR
activity increases at the end of larval development, as animals
stop eating and growing. (1) Activity of the unk reporter increases
in animals as they progress from larval to pupal stages (Fig-
ure S6A). (2) Knocking out REPTOR or REPTOR-BP has little
effect on basal (- rapamycin) levels of target genes in larvae (Fig-
ures 5B, 5B’, and S6B), suggesting that REPTOR activity is low
unless activated by nutrient withdrawal or rapamycin (Figures
5B and 5B’). In contrast, knocking out REPTOR in adults leads
to a clear reduction in basal levels of target genes (Figure S6B’).
Correspondingly, REPTORKO and REPTOR-BPKO animals do
not show strong phenotypes during larval stages under well-
fed conditions. They do not have reduced levels of stored nutri-
ents such as glycogen or triacylglycerides (TAG) (wandering
third-instar larvae [wL3]; Figures S6C and S6C’), and they are
not delayed in development (Figure S6D), indicating that their
rate of growth is normal. Consequently, the size of KO animals
is not reduced (Figure S6E), since the mass accumulation
occurs during larval stages. In contrast, as REPTORKO and
REPTOR-BPKO animals enter pupation and become adults,280 Developmental Cell 33, 272–284, May 4, 2015 ª2015 Elsevier Incthey display very strong metabolic phenotypes. REPTORKO
and REPTOR-BPKO pupae and adults have strongly reduced
TAG and glycogen levels (Figures 5C–5D’, S6C, and S6C’).
This leads to extreme sensitivity to starvation; REPTORKO and
REPTOR-BPKO flies die within 18 hr of starvation, whereas con-
trol animals survive up to 2.5 days without food (Figures 5E and
5E’). These phenotypes were rescued by re-introducing a leaky
UAS-REPTOR-BP transgene (Figure S6H) into the REPTOR-
BPKO background (Figures S5F and S5G) and phenocopied by
knocking down REPTOR with an RNAi construct in vivo (Fig-
ure S5I). In sum, REPTOR and REPTOR-BP play important roles
in the adult in regulating metabolic homeostasis and in enabling
flies to survive nutrient deprivation.
Since REPTOR/REPTOR-BP are inactive in larvae due to high
TORC1 activity during animal growth, this raised the possibility
that REPTOR/REPTOR-BP might be physiologically important
also in larvae if TORC1 activity is reduced. To achieve this, we
grew larvae on food diluted to 25% the usual concentration using
PBS/agarose. Under these conditions, control animals grow
slowly and yield small adults but are viable (Figure 5F). In
contrast, under these nutrient conditions, REPTORKO animals
display 50% lethality (Figure 5F). Therefore, REPTORKO animals
are sensitive to nutrient stress both during development and in
adulthood (Figures 5E and 5F). In contrast, REPTORKO were
not hypersensitive to oxidative stress (Figure 5F).
Since REPTOR and REPTOR-BP, like most transcription
factors, regulate expression of many genes, the REPTOR/REP-
TOR-BP KO phenotype likely results from the combined effects
of misregulation of many genes. Microarray analysis of fed
REPTORKO adult flies found 122 genes that are downregulated
(Table S6), among which are genes involved in gluconeogen-
esis and TAG biosynthesis (Figures S7C and S7D), and 86
genes that are upregulated (Table S6), among which are genes
involved in lipid or glycogen breakdown (Figures S7C and S7D).
Combined, these transcriptional changes likely contribute to
the leanness of REPTOR KOs. REPTOR target genes can
also be considered stress response genes, induced when
TORC1 is inactivated to cope with the stress. REPTORKO
adults have reduced expression of one such gene, 4E-BP (Fig-
ure S7C), which acts as a metabolic brake in tissues such as
muscle upon starvation (Teleman et al., 2005). Consistent
with this, muscle-specific knockdown of REPTOR partially
phenocopies the leanness of KO animals (Figures S7A and
S7A’). In sum, REPTOR and REPTOR-BP likely regulate organ-
ismal metabolism by acting on multiple genes in multiple tis-
sues, regulating, among other things, TAG biosynthesis and
organismal energy expenditure.
REPTOR and FOXO Have Overlapping Target Genes and
Interact Genetically
We noticed that FOXO-binding sites are enriched in the genomic
regions bound by REPTOR-BP (Figure S4F). Furthermore, 40%
of REPTOR targets (including 4E-BP) are also FOXO targets (p
value = 0, using a binomial distribution) (Teleman et al., 2008).
Since this suggests functional overlap between REPTOR and
FOXO, we asked whether REPTOR and FOXO interact geneti-
cally with each other. Indeed, whereas REPTOR and FOXO
homozygous mutants animals are viable, REPTOR, FOXO dou-
ble-mutant animals die as larvae (Figure 5G). Furthermore,.
Figure 6. REPTOR Partially Mediates TOR Mutant Phenotypes
(A and B) Loss of REPTOR rescues the obesity (A) and partially rescues the
growth defect (B) of TOR mutant larvae. Measurements performed on larvae
that were synchronized at first instar and grown under density-controlled
conditions for 4 days (4d) to pre-wL3. Ctrl, control. Error bars indicate SD.
**Student’s t test, p < 0.01. ***Student’s t test, p < 0.001; n.s., not significant.
Figure 7. Model of REPTOR Regulation
(A) When TORC1 is high, REPTOR activity is low, as is the case in feeding
larvae. REPTOR activity increases during development of the fly and becomes
fully activated upon nutrient withdrawal or rapamycin treatment. REPTOR
activity is kept in check by TORC1 phosphorylation and subsequent 14-3-3-
mediated cytoplasmic retention. When TORC1 activity drops, REPTOR be-
comes de-phosphorylated by PP2A, accumulates in the nucleus, binds target
genes together with REPTOR-BP, and induces their transcription.
(B) FOXO and REPTOR are the respective counterparts for insulin and TORC1
signaling, which sense nutrients at the organismal and cellular levels,
respectively.REPTOR and REPTOR-BP mutant animals have strongly
reduced lifespans (Figure S7E), a phenotype also observed in
FOXO mutants (Slack et al., 2011).
REPTOR and REPTOR-BP Mediate Part of the
Physiological Effects of TORC1
Since REPTOR is activated when TORC1 activity is reduced,
this raised the possibility that REPTOR/REPTOR-BP might be
mediating part of the physiological effects of reduced TORC1
activity. To this end, we tested whether removing REPTOR
can partly rescue TORC1 loss-of-function phenotypes. One
phenotype resulting from TORC1 inhibition is increased auto-
phagy. This could possibly be, in part, mediated by the activa-
tion of REPTOR. However, if anything, REPTOR KO larvae have
elevated, and not reduced, autophagy levels (Figure S7B), sug-
gesting that this is not the case. Larvae with reduced TOR ac-
tivity (TOR2L1/2L19) (Oldham et al., 2000) are fat and small in size
(Figures 6A and 6B). Prewandering REPTORKO larvae that were
well fed during development have neither size nor metabolic
phenotypes (Figure 6). Removing REPTOR in the TOR2L1/2L19
background significantly rescued both the metabolic pheno-
type and, surprisingly, the size phenotype of the TOR hypo-
morphs (Figures 6A and 6B). This suggests that TOR regulates
metabolism and promotes growth, in part, via repression of
REPTOR.
DISCUSSION
Here, we identify two uncharacterized genes, CG13624 and
CG18619, which we term REPTOR and REPTOR-BP, respec-
tively, as transcription factors mediating circa 90% of the tran-
scriptional repression downstream of TORC1 in Drosophila,
which indicates that they aremajor effectors of TORC1. REPTOR
is inhibited by TORC1-mediated phosphorylation and cyto-
plasmic retention by 14-3-3 proteins (Figure 7A). Upon nutrient
deprivation and low TORC1 activity, REPTOR becomes active,Devaccumulating in the nucleus and binding target genes, a process
that requires its partner, REPTOR-BP (Figure 7A).
REPTOR is repressed when TORC1 activity is high, as is the
case during larval stages when animals are feeding and growing.
Hence, genetic removal of REPTOR during larval stages of well-
fed animals has little phenotypic consequences, including no
growth defects. In contrast, REPTOR is somewhat activated in
(1) pupae and adults, which eat significantly less than larvae;
(2) in larvae growing in low-nutrient conditions; and (3) in S2 cells
growing in standard culture conditions. Hence, under these con-
ditions, REPTOR loss of function leads to transcriptional and
physiological phenotypes. The strongest REPTOR phenotypes
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conditions where TORC1 is most inactive and, hence, REPTOR
is most active (Figure 7A).
The REPTOR regulatory system is analogous to another
nutrient sensitive pathway—that of Akt and FOXO. When nutri-
ents are low, Akt becomes inactive due to reduced systemic in-
sulin signaling. This leads to FOXO dephosphorylation, release
from 14-3-3 proteins, and nuclear accumulation, thereby acti-
vating target genes that mount a stress response (Manning
and Cantley, 2007). FOXO and REPTOR can be thought of as
the respective counterparts for insulin and TORC1 signaling,
which sense nutrients at the systemic and cell-autonomous
levels, respectively (Figure 7B). FOXO and REPTOR also have
common target genes and bind near each other in shared en-
hancers. In sum, FOXO and REPTOR appear to have overlap-
ping functions; indeed, genetic removal of both REPTOR and
FOXO is synthetic lethal, indicating that they compensate for
loss of each other.
As an effector of TORC1 function, REPTOR mediates some of
the physiological effects of reduced TORC1 activity. Body-wide
inhibition of TORC1 signaling leads to increased TAG levels (Bje-
dov et al., 2010; Murillo-Maldonado et al., 2011; Teleman et al.,
2005) and animals of reduced size (Oldham et al., 2000; Zhang
et al., 2000). These phenotypes are, in part, due to activation
of REPTOR, since removal of REPTOR strongly rescues them.
Thus, TORC1 promotes growth during development not only
by activating S6K but also by keeping REPTOR/REPTOR-BP
repressed. Inhibition of TORC1 also extends lifespan (Bjedov
et al., 2010; Kapahi et al., 2004). This could potentially be
mediated, in part, via activation of REPTOR/REPTOR-BP, since
both REPTOR and REPTOR-BP KO animals have significantly
reduced lifespans (Figure S7E).
We quantified triglyceride levels in TOR2L1/2L19 hypomorphic
larvae and found them to be significantly elevated compared to
those in controls (Figure 6A), in line with a number of reports
from adult flies (Bjedov et al., 2010; Bo¨hni et al., 1999; Broughton
et al., 2005; Haselton et al., 2010;Murillo-Maldonado et al., 2011;
Teleman et al., 2005). Our results do not fit with one report that
dTOR7/P mutant larvae are lean (Luong et al., 2006). We do not
know the reason for this discrepancy or whether it has to do
with the particular nature of the dTOR[7] and/or dTOR[P] alleles.
Further work will be required to examine this carefully.
Both REPTOR and REPTOR-BP proteins have DBDs. Hence,
the DNA-binding specificity of the REPTOR/REPTOR-BP dimer
likely reflects the combined action of the two proteins. Since
REPTOR-BP can also homodimerize, the REPTOR-BP homo-
dimer might bind DNA with a pattern distinct from that of the
REPTOR/REPTOR-BP dimer.
Many of the genes repressed by rapamycin in larvae (80%)
were no longer repressed by rapamycin in REPTOR KO larvae,
raising the possibility that these genes are also REPTOR targets.
We do not think, however, that this is the case for several rea-
sons. (1) In S2 cells, almost no genes require REPTOR to be
repressed by rapamycin. If REPTOR were also involved in tran-
scriptional repression, we think we would likely see this also in
S2 cells. (2) The REPTOR-induced genes are in common be-
tween S2 cells and larvae, whereas the REPTOR-repressed
ones are not, suggesting their regulation might result from
indirect effects. (3) Transactivation assays with REPTOR and
REPTOR-BP only show strong transcriptional activation of the282 Developmental Cell 33, 272–284, May 4, 2015 ª2015 Elsevier Increporters but no repression. That said, many transcription com-
plexes have both activating and repressive activities, so further
investigation might find that REPTOR and REPTOR-BP also
have repressive functions.
Surprisingly, REPTOR and REPTOR-BP have attracted little
attention to date.
Microarray studies found that expression of CG13624 and
CG18619 are regulated by nutrient conditions in the fly (Teleman
et al., 2008; Zinke et al., 2002); however, no information
regarding their function was available. Using BLAST to compare
the human proteome with REPTOR and REPTOR-BP identifies
Crebrf and Crebl2, respectively, which could potentially be hu-
man orthologs. It will be interesting to study them in light of our
Drosophila data.
In summary, this study identifies REPTOR and REPTOR-BP as
dedicated transcription factors that control the transcriptional
repression downstream of TORC1 in Drosophila. Since these
transcription factors mediate part of the functional output of
TORC1, it will be interesting to assess their contribution toward
the role that TORC1 plays in cancer, diabetes, and aging.
EXPERIMENTAL PROCEDURES
Fly Stocks
All chromosomes and flies used for metabolic measurements and growth ex-
periments were backcrossed tow1118 at least five times and reared on density-
controlled conditions before the experiment. For control flies, we used
isogenic w1118 flies from the Bloomington Drosophila Stock Center. TOR2L1
and TOR2L19 flies were described in Oldham et al. (2000), and FOXOD94 flies
were described in Slack et al. (2011).
Metabolic Measurements
For TAG and glycogen measurements, 60 first-instar larvae were seeded per
vial to grow under defined density conditions. Hatching adults were collected
within a 12-hr window and allowed to age 3 or 4 days as indicated prior to ho-
mogenization for quantification of TAG or glycogen levels.
Rapamycin and Starvation Treatments
Starvation experiments were conducted on 0.8% agarose/13 PBS. Rapamy-
cin feeding was conducted by mixing normal food with 200 mM (final) rapamy-
cin (Santa Cruz Biotechnology, sc-3504A) dissolved in EtOH. Control food
contained EtOH at the same concentration as rapamycin food. Adult flies
were fed 3 days with rapamycin, and larvae were fed for 30 min–6 hr, depend-
ing on the experiment.
Antibodies
REPTOR and phosphoREPTOR antibodies were raised by immunizing guinea
pigs and rabbits respectively, with keyhole limpet hemocyanin (KLH)-conju-
gated peptides. 14-3-3 antibodies were raised by immunizing full-length pro-
teins in guinea pigs.
Cell Culture and Luciferase Assays
Drosophila S2 cells were cultured at 25C in Schneider’s Drosophila medium
(GIBCO 21720), supplemented with penicillin/streptomycin and 10% fetal
calf serum (FCS). dsRNA was generated by performing a T7 transcription re-
action from an amplified genomic region of the respective gene. Gene
knockdowns were performed by treating S2 cells with 12 mg/ml dsRNA in
serum-free medium for 1 hr. Cells were then given serum-containing medium
and allowed to grow for 5 days before analysis to allow for the knockdown to
take effect.
For luciferase assays, S2 cells were transfected overnight with indicated
plasmids and then treated for 6 hr with rapamycin, EtOH, or Torin1. Then, cells
were lysed and analyzed using the Dual-Luciferase Reporter Assay System
(Promega, E1910)..
Transactivation Assay
The DBD of GAL4 was fused to REPTOR and REPTOR-BP. Either one was ex-
pressed along with a 53UAS >> hsp70 >> FLuc reporter plasmid and a
normalization control plasmid hsp70 >> RLuc. Fusion protein expression
was induced with copper overnight. Samples were analyzed using the Dual-
Luciferase Reporter Assay System (Promega, E1910).
ChIP
S2 cells were crosslinked with 1% formaldehyde for 10 min, blocked with
glycine for 5 min, washed with cold PBS, and lysed in shearing buffer
(0.8% SDS, Tris, EDTA, protease inhibitor cocktail) for 10 min on ice. Samples
were subjected to sonication in a Bioruptor (Diaenode) for 23 cycles, 30 s/30 s
on/off, at ‘‘high’’ intensity until fragment size was between 150 and 500 bp. 1%
input was taken, and the rest was used for immunoprecipitation (IP) with indi-
cated antibodies. Elution of IP and preparation of input were performed by
incubating bead-bound chromatin and EtOH-precipitated input pellet with
10% Chelex solution (Sigma, C7901) at 95C for 15 min, and treatment was
performed with Proteinase K for 30 min at 50C and another 10 min at 95C.
The Chelex supernatant was diluted 1:3 before analysis by qPCR.
Data and Analyses
Statistical significance in the figures was calculated using Student’s t tests.
Supplemental Experimental Procedures, including the number of technical
and biological replicates for all figure panels, are available in the Supplemental
Information.
ACCESSION NUMBERS
Microarray data are deposited at the NCBI Gene Expression Omnibus with
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